Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis-Reference-Cited by-同舟云学术

Hippocampal Glutamate and Positive Symptom Severity in Clinical High Risk for Psychosis

Published:2022-02-01 Issue:2 Volume:79 Page:178
ISSN:2168-622X
Container-title:JAMA Psychiatry
language:en
Short-container-title:JAMA Psychiatry

Author:

Basavaraju Rakshathi¹,Guo Jia²,Small Scott A.¹,Lieberman Jeffrey A.²,Girgis Ragy R.²,Provenzano Frank A.¹

Affiliation:

1. Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Department of Neurology, Columbia University Medical Center, New York, New York

2. New York State Psychiatric Institute, Department of Psychiatry, Columbia University Medical Center, New York

Publisher

American Medical Association (AMA)

Subject

Psychiatry and Mental health

Link

https://jamanetwork.com/journals/jamapsychiatry/articlepdf/2787219/jamapsychiatry_basavaraju_2021_ld_210014_1643689386.6995.pdf

Reference6 articles.

1. The psychosis high-risk state: a comprehensive state-of-the-art review.;Fusar-Poli;JAMA Psychiatry,2013

2. Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.;Lieberman;Mol Psychiatry,2018

3. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver.;Schobel;Neuron,2013

4. Hippocampal hyperactivity as a druggable circuit-level origin of aberrant salience in schizophrenia.;Kätzel;Front Pharmacol,2020

5. Hippocampal pathology in clinical high-risk patients and the onset of schizophrenia.;Provenzano;Biol Psychiatry,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RETRACTED: Left hemisphere lateralization of the limbic system and frontoparietal network (FPN) correlates with positive and negative symptom improvement following cannabidiol (CBD) administration in psychosis and ultra-high risk (UHR) populations: A voxel-wise meta-analysis;Journal of Psychiatric Research;2024-07

2. Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk;2023-03-05

3. Hippocampal Glutamate, Resting Perfusion and the Effects of Cannabidiol in Psychosis Risk;Schizophrenia Bulletin Open;2023-01-01

4. Research Trends in Individuals at High Risk for Psychosis: A Bibliometric Analysis;Frontiers in Psychiatry;2022-04-29